ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1959

Color Doppler Ultrasonography Appears to Perform Better Than Magnetic Resonance Angiography in the Diagnostics of Patients with Systemic Large Vessel Vasculitis

Andreas P Diamantopoulos1,2, Julia Geiger3, Frode Lohne4, Geirmund Myklebust5 and Wolfgang A. Schmidt6, 1Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 2Rheumatology, Haugesund Hospital for Rheumatic Diseases, Haugesund, Norway, 3Department of Radiology, University Children's Hospital, Zurich, Switzerland, 4Radiology, Hospital of Southern Norway Trust, Kristiansand, Norway, 5Rheumatology, Hospital of Southern Norway, Kristiansand, Norway, 6Medical Center for Rheumatology and Clinical Immunology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Diagnostic imaging, large vessel vasculitis, Magnetic resonance imaging (MRI), ultrasonography and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Vasculitis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Color Doppler ultrasound (CDUS) and
Magnetic resonance angiography (MRA) has been extensively used in the
diagnostics of large vessel vasculitis (LVV) [giant cell arteritis (GCA) and
Takayasu arteritis (TA)]. No studies exist, which compare the diagnostic
accuracy of CDUS and MRA of LVV in the supra-aortic large vessels. The aim of
this study is to perform a head-to-head comparison between CDUS and MRA of
temporal arteries and supra-aortic large vessels in a group of LVV patients.

Methods:

MUSES (Magnetic resonance
angiography vs Ultrasonography in Systemic large vEssel vasculitis, Clinical
Trials.gov NCT02042092), is a prospective cross-sectional study. Patients
diagnosed with LVV by ultrasound, MRA, Computed Tomography Angiography or
Positron Emission Tomography, were identified and included in MUSES at the
Department of Rheumatology, in Kristiansand between January 2014 and January
2015. One ultrasonographer experienced in the use of vascular ultrasound (APD)
examined and recruited the LVV patients. MRA imaging was performed within one
week after the ultrasound evaluation and one radiologist evaluated the MRA
images locally (FL). The common temporal, carotid, subclavian, vertebral,
axillary arteries and the thoracic aorta were evaluated. Films and images of CDUS
and MRA examinations were recorded.  The recorded data has been surveyed by two
external experts, one on vascular ultrasound (WAS) and one on MR imaging (JG).
Both experts were blinded to clinical and laboratory data and were unaware of distribution
and size of the vasculitis lesions. The experts applied a dichotomous score
(vasculitis: yes/no) in every evaluated vessel. The identification of vasculitis
in any vessel represented an independent result.

Results:

Twenty-seven patients were
recruited [(12 males, 15 females, median
age 69 years (IQR 62-76)]. Twenty-five patients were diagnosed with GCA and 2
with TA. Eight patients had new onset LVV and 19 had long lasting disease (median
disease duration 2 years, IQR 0-5). Median time between CDUS and MRA
examination was 2 days (IRQ 1-4). Median CRP was 8 mg/l (IQR 3-24) and ESR 24 mm/hr.
(IQR 9-53). In two patients, no vasculitis changes were observed in any vessel,
either on CDUS or MRA. In the remaining 25 patients, CDUS revealed vasculitis
in all patients, while MRA was positive in 20 patients. The temporal artery and
the supra-aortic vessels in which CDUS, MRA or both modalities revealed
vasculitis changes are presented in table 1.

Conclusion:

It seems that CDUS is more sensitive to detect
vasculitis changes in large vessels. Further, CDUS revealed vasculitis in more
patients than MRA. Thus, we recommend CDUS as a first line evaluation in all
patients suspected to have LVV.  

Table 1.

 

CDUS vasculitis only

MRA vasculitis only

Vasculitis in both modalities

Left common temporal

2

1

10

Left parietal temporal

6

1

8

Left frontal temporal

2

3

7

Right common temporal

3

6

7

Right parietal temporal

2

5

8

Right frontal temporal

2

7

8

Left carotid

13

1

1

Right carotid

12

0

4

Left subclavian

10

1

5

Right subclavian

5

1

3

Left vertebral

3

0

0

Right vertebral

2

0

0

Left axillary

11

0

3

Right axillary

15

1

4

Thoracic aorta

2

0

0

 

 


Disclosure: A. P. Diamantopoulos, None; J. Geiger, None; F. Lohne, None; G. Myklebust, None; W. A. Schmidt, GlaxoSmithKline, 5,Roche Pharmaceuticals, 5,Roche Pharmaceuticals, 8.

To cite this abstract in AMA style:

Diamantopoulos AP, Geiger J, Lohne F, Myklebust G, Schmidt WA. Color Doppler Ultrasonography Appears to Perform Better Than Magnetic Resonance Angiography in the Diagnostics of Patients with Systemic Large Vessel Vasculitis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/color-doppler-ultrasonography-appears-to-perform-better-than-magnetic-resonance-angiography-in-the-diagnostics-of-patients-with-systemic-large-vessel-vasculitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/color-doppler-ultrasonography-appears-to-perform-better-than-magnetic-resonance-angiography-in-the-diagnostics-of-patients-with-systemic-large-vessel-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology